USA Financial Portformulas Corp Buys New Position in Exponent, Inc. (EXPO)

USA Financial Portformulas Corp bought a new stake in Exponent, Inc. (NASDAQ:EXPO) in the third quarter, HoldingsChannel.com reports. The firm bought 6,947 shares of the business services provider’s stock, valued at approximately $336,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in EXPO. Strs Ohio bought a new position in Exponent during the 2nd quarter valued at approximately $101,000. Fort L.P. bought a new position in Exponent during the 2nd quarter valued at approximately $117,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Exponent by 100.0% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,952 shares of the business services provider’s stock valued at $143,000 after buying an additional 1,476 shares in the last quarter. KBC Group NV bought a new position in Exponent during the 2nd quarter valued at approximately $150,000. Finally, Benjamin F. Edwards & Company Inc. increased its position in Exponent by 2,500.0% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 3,250 shares of the business services provider’s stock valued at $157,000 after buying an additional 3,125 shares in the last quarter. Institutional investors own 89.14% of the company’s stock.

A number of research analysts recently weighed in on the company. Berenberg Bank assumed coverage on Exponent in a research report on Wednesday, September 12th. They set a “buy” rating for the company. BidaskClub lowered Exponent from a “strong-buy” rating to a “buy” rating in a research report on Thursday, September 20th. Zacks Investment Research raised Exponent from a “hold” rating to a “buy” rating and set a $55.00 price objective for the company in a research report on Monday, October 22nd. Finally, SunTrust Banks raised their price objective on Exponent to $56.00 and gave the company a “buy” rating in a research report on Friday, July 20th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $45.00.

In other Exponent news, insider Harri Kytomaa sold 7,000 shares of Exponent stock in a transaction on Friday, October 26th. The stock was sold at an average price of $49.00, for a total value of $343,000.00. Following the completion of the sale, the insider now owns 13,090 shares of the company’s stock, valued at approximately $641,410. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.70% of the stock is currently owned by company insiders.

EXPO stock opened at $50.69 on Monday. Exponent, Inc. has a twelve month low of $34.90 and a twelve month high of $54.58. The company has a market cap of $2.64 billion, a P/E ratio of 47.37 and a beta of 0.61.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, October 18th. The business services provider reported $0.32 EPS for the quarter, topping the Zacks’ consensus estimate of $0.29 by $0.03. The business had revenue of $88.71 million during the quarter, compared to analyst estimates of $88.52 million. Exponent had a return on equity of 20.92% and a net margin of 13.98%. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.27 EPS. On average, equities analysts forecast that Exponent, Inc. will post 1.31 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 21st. Shareholders of record on Friday, December 7th will be issued a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date is Thursday, December 6th. Exponent’s payout ratio is 48.60%.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Featured Article: Dow Jones Industrial Average (DJIA)

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply